Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aus G, Abbou CC, Bolla M et al. EAU guidelines on prostate cancer. Eur Urol 2005; 48(4):546–551.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57(1):43–66.
Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997; 50(4):562–566.
O'Dowd GJ, Miller MC, Orozco R, Veltri RW. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis. Urology 2000; 55(4):553–558.
Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res 1986; 46(2):467–473.
Takahashi H, Ouchi T. The ultrasonic diagnosis in the field of urology. Proc Jpn Soc Ultrasonics Med 1963; 3:7–8.
Watanabe H, Kaiho H, Tanaka M, Terasawa Y. Diagnostic application of ultrasonotomography to the prostate. Invest Urol 1971; 8(5):548–559.
Watanabe H, Igari D, Tanahasi Y, Harada K, Saito M. Development and application of new equipment for transrectal ultra-sonography. J Clin Ultrasound 1974; 2(2):91–98.
Terris MK, Stamey TA. Determination of prostate volume by transrectal ultrasound. J Urol 1991; 145(5):984–987.
Bates TS, Reynard JM, Peters TJ, Gingell JC. Determination of prostatic volume with transrectal ultrasound: A study of intra-observer and interobserver variation. J Urol 1996; 155(4):1299– 1300.
Terris MK, Freiha FS, Mcneal JE, Stamey TA. Efficacy of tran-srectal ultrasound for identification of clinically undetected prostate-cancer. J Urol 1991; 146(1):78–84.
Hodge KK, Mcneal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided trans-rectal core biopsies of the prostate. J Urol 1989; 142(1):71–75.
Sedelaar JPM, Vijverberg PLM, de Reijke TM et-al. Transrectal ultrasound in the diagnosis of prostate cancer: State of the art and perspectives. Eur Urol 2001; 40(3):275–284.
Beerlage H, de Reijke TM, De la Rosette JJMC. Considerations regarding prostate biopsies. Eur Urol 1998; 34(4):303–312.
Toi A, Neill MG, Lockwood GA, Sweet JM, Tammsalu LA, Fleshner NE. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007; 177(2):516–520.
Ukimura O, Gill IS, Desai MM et al. Real-time transrectal ultra-sonography during laparoscopic radical prostatectomy. J Urol 2004; 172(1):112–118.
Ukimura O, Gill IS. Real-time transrectal ultrasound guidance during nerve sparing laparoscopic radical prostatectomy: Pictorial essay. J Urol 2006; 175(4):1311–1319.
Ukimura O, Magi-Galluzzi C, Gill IS. Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: Impact on surgical margins. J Urol 2006; 175(4):1304–1310.
Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang ZH, Baust J. Transrectal ultrasound-guided percutaneous radical cryosurgi-cal ablation of the prostate. Cancer 1993; 72(4):1291–1299.
Gelet A, Chapelon JY, Margonari J et al. High-intensity focused ultrasound experimentation on human benign prostatic hypertrophy. Eur Urol 1993; 23:44–47.
Aus G. Current status of HIFU and cryotherapy in prostate cancer – A review. Eur Urol 2006; 50(5):927–934.
Wallner K, Chiutsao ST, Roy J, Rosenstein M, Smith H, Fuks Z. A new device to stabilize templates for transperineal I-125 implants. Int J Radiat Oncol Biol Phys 1991; 20(5):1075–1077.
Rifkin MD, Sudakoff GS, Alexander AA. Prostate – Techniques, results, and potential applications of color Doppler US scanning. Radiology 1993; 186(2):509–513.
Leventis AK, Shariat SF, Utsunomiya T, Slawin KM. Characteristics of normal prostate vascular anatomy as displayed by power Doppler. Prostate 2001; 46(4):281–288.
Cornud F, Hamida K, Flam T et al. Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: Correlation with radical prostatectomy findings. Am J Roentgenol 2000; 175(4):1161–1168.
Halpern EJ, Strup SE. Using gray-scale and color and power Doppler sonography to detect prostatic cancer. Am J Roentgenol 2000;174(3):623–627.
Remzi M, Dobrovits M, Reissigl A et al. Can power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy? Eur Urol 2004; 46(4):451–456.
Tong SD, Cardinal HN, McLoughlin RF, Downey DB, Fenster A. Intra- and inter-observer variability and reliability of prostate volume measurement via two-dimensional and three-dimensional ultrasound imaging. Ultrasound Med Biol 1998; 24(5):673–681.
Strasser H, Janetschek G, Reissigl A, Bartsch G. Prostate zones in three-dimensional transrectal ultrasound. Urology 1996; 47(4):485–490.
Sedelaar JPM, van Roermund JGH, van Leenders GLJH, Huls-bergen-van de Kaa CA, Wijkstra H, De la Rosette JJMC. Three-dimensional grayscale ultrasound: Evaluation of prostate cancer compared with benign prostatic hyperplasia. Urology 2001; 57(5):914–920.
Ophir J, Cespedes I, Ponnekanti H, Yazdi Y, Li X. Elastography – A quantitative method for imaging the elasticity of biological tissues. Ultrasonic Imaging 1991; 13(2):111–134.
Konig K, Scheipers U, Pesavento A, Lorenz A, Ermert H, Senge T. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol 2005; 174(1):115–117.
Cochlin DL, Ganatra RH, Griffiths DFR. Elastography in the detection of prostatic cancer. Clin Radiol 2002; 57(11):1014– 1020.
Wefer AE, Hricak H, Vigneron DB et al. Sextant localization of prostate cancer: Comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 2000; 164(2):400–404.
Kirkham APS, Emberton M, Allen C. How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 2006; 50(6):1163–1175.
Hara N, Okuizumi M, Koike H, Kawaguchi M, Bilim V. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer. Prostate 2005; 62(2):140–147.
Flanigan RC, Mckay TC, Olson M, Shankey TV, Pyle J, Waters WB. Limited efficacy of preoperative computed tomographic scanning for the evaluation of lymph node metastasis in patients before radical prostatectomy. Urology 1996; 48(3):428–432.
Carey BM. Imaging for prostate cancer. Clin Oncol 2005; 17(7):553–559.
Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol 1968; 3(5):356–366.
Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol 2006; 60(3):324–330.
Correas JM, Bridal L, Lesavre A, Mejean A, Claudon M,Helenon O. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11(8):1316–1328.
Jakobsen JA, Oyen R, Thomsen HS, Morcos SK. Safety of ultrasound contrast agents. Eur Radiol 2005; 15(5):941–945.
Wink MH, Wijkstra H, De la Rosette JJMC, Grimbergen CA. Ultrasound imaging and contrast agents: A safe alternative to MRI? Minim Invasive Ther Allied Technol 2006; 15(2):93–100.
Bokor D, Chambers JB, Rees PJ, Mant TG, Luzzani F, Spinazzi A. Clinical safety of SonoVue, a new contrast agent for ultrasound imaging, in healthy volunteers and in patients with chronic obstructive pulmonary disease. Invest Radiol 2001; 36(2): 104 – 109.
Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med 2004; 25(4):249– 256.
Lang RM, Mor-Avi V. Clinical utility of contrast-enhanced echocardiography. Clin Cardiol 2006; 29(9 Suppl 1):I15–I25.
Catalano O, Nunziata A, Lobianco R, Siani A. Real-time harmonic contrast material-specific US of focal liver lesions. Radio-graphics 2005; 25(2):333–349.
Meloni MF, Livraghi T, Filice C, Lazzaroni S, Calliada F, Perretti L. Radiofrequency ablation of liver tumors: the role of microbub-ble ultrasound contrast agents. Ultrasound Q 2006; 22(1):41–47.
Forsberg F, Goldberg BB, Merritt CRB et al. Diagnosing breast lesions with contrast-enhanced 3-dimensional power Doppler imaging. J Ultrasound Med 2004; 23(2):173–182.
Rizzatto G, Martegani A, Chersevani R et al. Importance of staging of breast cancer and role of contrast ultrasound. Eur Radiol 2001; 11:E47–E51.
Postert T, Braun B, Meves S et al. Contrast-enhanced transcranial color-coded sonography in acute hemispheric brain infarction. Stroke 1999; 30(9):1819–1826.
Wisner ER, Ferrara KW, Short RE, Ottoboni TB, Gabe JD, Patel D. Sentinel node detection using contrast-enhanced power Doppler ultrasound lymphography. Invest Radiol 2003; 38(6):358–365.
Tafuto S, Catalano O, Barba G et al. Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lympho-mas. Front Biosci 2006; 11:2224–2229.
Thorelius L. Contrast-enhanced ultrasound in trauma. Eur Radiol 2004; 14:43–52.
Pelzer A, Bektic J, Berger AP et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 2005; 173(6):1926–1929.
Sedelaar JPM, van Leenders GJLH, Goossen TEB et al. Value of contrast ultrasonography in the detection of significant prostate cancer: Correlation with radical prostatectomy specimens. Prostate 2002; 53(3):246–253.
Sedelaar JPM, van Leenders GJLH, Hulsbergen-van de Kaa CA et al. Microvessel density: Correlation between contrast ultra-sonography and histology of prostate cancer. Eur Urol 2001; 40(3):285–293.
Goossen TEB, De la Rosette JJMC, De Kaa CAHV, van Leen-ders GJLH, Wijkstra H. The value of dynamic contrast enhanced power Doppler ultrasound Imaging in the localization of prostate cancer. Eur Urol 2003; 43(2):124–131.
Frauscher F, Klauser A, Halpern EJ, Horninger W, Bartsch G. Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet 2001; 357(9271):1849–1850.
Frauscher F, Klauser A, Volgger H et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: Impact on prostate cancer detection. J Urol 2002; 167(4):1648–1652.
Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: Contrast-enhanced US for detection. Radiology 2001 ; 219 (1) : 219 – 225.
RoyC,BuyX,LangH,SaussineC,JacqminD.Contrast enhanced color Doppler endorectal sonography of the prostate: Efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003; 170(1):69–72.
Bogers HA, Sedelaar JPM, Beerlage HP et al. Contrast-enhanced three-dimensional power Doppler angiography of the human prostate: Correlation with biopsy outcome. Urology 1999; 54(1):97–104.
Zaider M, Zelefsky MJ, Lee EK et al. Treatment planning for prostate implants using magnetic-resonance spectroscopy imaging. Int J Radiat Oncol Biol Phys 2000; 47(4):1085–1096.
Sedelaar JPM, Aarnink RG, van Leenders GJLH et al. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer. Eur Urol 2000; 37(5):559–568.
Eckersley RJ, Sedelaar JPM, Blomley MJK et al. Quantitative microbubble enhanced transrectal ultrasound as a tool for monitoring hormonal treatment of prostate carcinoma. Prostate 2002; 51(4):256–267.
Lamuraglia M, Escudier B, Chami L et al. To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound. Eur J Cancer 2006; 42(15):2472–2479.
Lindner JR. Evolving applications for contrast ultrasound. Am J Cardiol 2002; 90(10A):72J–80J.
Weller GER, Wong MKK, Modzelewski RA et al. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. Cancer Res 2005; 65(2):533–539.
Lindner JR. Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol 2004; 11(2):215–221.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag London Limited
About this chapter
Cite this chapter
Wondergem, N., Rosette, J.J.M.C.H.d. (2009). Contrast-Enhanced Ultrasound for the Prostate. In: Ukimura, O., Gill, I.S. (eds) Contemporary Interventional Ultrasonography in Urology. Springer, London. https://doi.org/10.1007/978-1-84800-217-3_12
Download citation
DOI: https://doi.org/10.1007/978-1-84800-217-3_12
Publisher Name: Springer, London
Print ISBN: 978-1-84800-216-6
Online ISBN: 978-1-84800-217-3
eBook Packages: MedicineMedicine (R0)